Endocrine Testing Market Industry Analysis and Forecast 2029

Endocrine Testing Market – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning / Landscape Review & Global Market Size Forecast to 2029

8.5%

CAGR (2023-2029)

13.85 USD Bn.

Market Size

322

Report Pages

133

Market Tables

Overview

Endocrine Testing Market is expected to reach US$ 24.52 Bn. at a CAGR of 8.5 % during the forecast period 2029.

Global Endocrine Testing Market, Dynamics:

The endocrine system plays a vital role in reproduction, growth and sexual development, retorts to injury and stress, body energy levels, bone and muscle strength, and also internal balance of the body.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

The growing incidence of hormonal imbalances in individuals is one of the key drivers in the global endocrine testing market. The changing lifestyles, growing stress, and unhealthy food habits result in improved obesity and disturbed hormonal changes are some of the driving factors behind the growth in the global endocrine testing market. To know about the Research Methodology :- Request Free Sample Report

The software has been designed to accomplish the workflow in the laboratories. Newer mobile apps have been presented wherein a patient can be reminded about his appointment or test, and he will be able to contact a physician. These advancements in technology are projected to propel the global endocrine testing market growth over the forecast period.

On the other hand, the high cost of technology is projected to be the key restraint for the growth of the global endocrine testing market. Furthermore, an increase in the investment in research and technology is measured as a major opportunity for the growth of the global endocrine testing market.

The thyroid-stimulating hormone (TSH) test is expected to share significant growth in the global endocrine testing market. The significant growth in the market is attributed to the growing incidences of TSH-related disorders and the rising awareness regarding the correlation between variations in the thyroid hormone levels and cardiovascular disorders. Furthermore, the Insulin test is expected to grow at a xx % rate of CAGR during the forecast period. The considerable rise in the diabetic population and the rising awareness about diagnosis are expected to contribute towards the demand for an insulin test.

The tandem mass spectrometry is estimated to hold a dominant position in the global endocrine testing market followed by sensor technology segment. The growing use of tandem mass spectrometry in combination with liquid chromatography, which also helps in overcoming the challenges associated with traditional techniques is expected to increase the demand for tandem mass spectrometry. On the other hand, sensor technology is projected to grow at a xx % rate of CAGR during the forecast period owing to the increasing use of biosensors in glucose monitoring for diabetes which is used on routine basis by the individuals to monitor their blood sugar level.

Global Endocrine Testing Market Regional Analysis:

Geographically, North America region is estimated to contribute a significant share in the global endocrine testing market. Growing incidence of several types of endocrine diseases, rapid adoption of novel testing techniques supported by regulatory infrastructure and positive recompense scenario are the some of the prominent factors behind the growth in the global endocrine testing market.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding dynamics, structure by analysing the market segments and, project the global endocrine testing market. The report also provides a clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global endocrine testing market. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders in arranging the efforts and investment in the near future to a particular market segment.

Global Endocrine Testing Market, Key Highlights:

Global Endocrine Testing Market analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Market

Global Endocrine Testing Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

Global Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Endocrine Testing Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Market are also profiled.

Global Endocrine Testing Market Scope: Inquire before buying

Global Endocrine Testing Market
Report Coverage	Details
Base Year:	2022	Forecast Period:	2023-2029
Historical Data:	2018 to 2022	Market Size in 2022:	US $ 13.85 Bn.
Forecast Period 2023 to 2029 CAGR:	8.5%	Market Size in 2029:	US $ 24.52 Bn.
Segments Covered:	by Test	Follicle stimulating hormone (FSH) Human Chorionic Gonadotropin (hCG) Thyroid Stimulating Hormone (TSH) Dehydroepiandrosterone sulphate (DHEAS) Prolactin Progesterone Insulin Cortisol Testosterone Estradiol (E2) Luteinizing Hormone (LH)
	by Technology	Immunoassay Clinical Chemistry Monoclonal and Polyclonal Antibody Sensor technology Tandem Mass Spectroscopy
	by End User	Hospitals Physician Offices Health Care Centers Commercial Laboratories

Global Endocrine Testing Market, by Region

, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Global Endocrine Testing Market Key players

1. Thermo Fisher Scientific, Inc.
2. Quest Technology
3. Biomedical Technologies.
4. Sysmex Corporation
5. Abbott Laboratories
6. AB Sciex Pte. Ltd.
7. Agilent Technologies
8. Siemens Healthcare
9. Ortho Clinical Technology
10.BioMerieux SA
11.Bio-Rad Laboratories
12.DiaSorin S.p.A
13.F. Hoffmann-La Roche Ltd.
14.Laboratory Corporation of America Holdings
15.Hoffmann-La Roche Ltd.
16.LabCorp
17.Alfa Aesar
18.Laboratory Corporation of America Holdings (LabCorp)
19.Beckman Coulter Inc
20.Teleflex Inc

Frequently Asked Questions:

1. Which region has the largest share in Global Endocrine Testing Market?
Ans: North America region holds the highest share in 2022.

2. What is the growth rate of Global Endocrine Testing Market?
Ans: The Global Market is growing at a CAGR of 8.5% during forecasting period 2023-2029.

3. What is scope of the Global market report?
Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global market?
Ans: The important key players in the Global Market are – Thermo Fisher Scientific, Inc., Quest Technology, Biomedical Technologies., Sysmex Corporation, Abbott Laboratories, AB Sciex Pte. Ltd., Agilent Technologies, Siemens Healthcare, Ortho Clinical Technology, BioMerieux SA, Bio-Rad Laboratories, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Hoffmann-La Roche Ltd., LabCorp, Alfa Aesar, Laboratory Corporation of America Holdings (LabCorp), Beckman Coulter Inc, and Teleflex Inc

5. What is the study period of this market?
Ans: The Global Market is studied from 2022 to 2029.

1. Endocrine Testing Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Endocrine Testing Market: Dynamics 2.1. Endocrine Testing Market Trends by Region 2.1.1. North America Endocrine Testing Market Trends 2.1.2. Europe Endocrine Testing Market Trends 2.1.3. Asia Pacific Endocrine Testing Market Trends 2.1.4. Middle East and Africa Endocrine Testing Market Trends 2.1.5. South America Endocrine Testing Market Trends 2.2. Endocrine Testing Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Endocrine Testing Market Drivers 2.2.1.2. North America Endocrine Testing Market Restraints 2.2.1.3. North America Endocrine Testing Market Opportunities 2.2.1.4. North America Endocrine Testing Market Challenges 2.2.2. Europe 2.2.2.1. Europe Endocrine Testing Market Drivers 2.2.2.2. Europe Endocrine Testing Market Restraints 2.2.2.3. Europe Endocrine Testing Market Opportunities 2.2.2.4. Europe Endocrine Testing Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Endocrine Testing Market Drivers 2.2.3.2. Asia Pacific Endocrine Testing Market Restraints 2.2.3.3. Asia Pacific Endocrine Testing Market Opportunities 2.2.3.4. Asia Pacific Endocrine Testing Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Endocrine Testing Market Drivers 2.2.4.2. Middle East and Africa Endocrine Testing Market Restraints 2.2.4.3. Middle East and Africa Endocrine Testing Market Opportunities 2.2.4.4. Middle East and Africa Endocrine Testing Market Challenges 2.2.5. South America 2.2.5.1. South America Endocrine Testing Market Drivers 2.2.5.2. South America Endocrine Testing Market Restraints 2.2.5.3. South America Endocrine Testing Market Opportunities 2.2.5.4. South America Endocrine Testing Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Endocrine Testing Industry 2.8. Analysis of Government Schemes and Initiatives For Endocrine Testing Industry 2.9. Endocrine Testing Market Trade Analysis 2.10. The Global Pandemic Impact on Endocrine Testing Market 3. Endocrine Testing Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Endocrine Testing Market Size and Forecast, by Test (2022-2029) 3.1.1. Follicle stimulating hormone (FSH) 3.1.2. Human Chorionic Gonadotropin (hCG) 3.1.3. Thyroid Stimulating Hormone (TSH) 3.1.4. Dehydroepiandrosterone sulphate (DHEAS) 3.1.5. Prolactin 3.1.6. Progesterone 3.1.7. Insulin 3.1.8. Cortisol 3.1.9. Testosterone 3.1.10. Estradiol (E2) 3.1.11. Luteinizing Hormone (LH) 3.2. Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 3.2.1. Immunoassay 3.2.2. Clinical Chemistry 3.2.3. Monoclonal and Polyclonal Antibody 3.2.4. Sensor technology 3.2.5. Tandem Mass Spectroscopy 3.3. Endocrine Testing Market Size and Forecast, by End User (2022-2029) 3.3.1. Hospitals 3.3.2. Physician Offices 3.3.3. Health Care Centers 3.3.4. Commercial Laboratories 3.4. Endocrine Testing Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Endocrine Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Endocrine Testing Market Size and Forecast, by Test (2022-2029) 4.1.1. Follicle stimulating hormone (FSH) 4.1.2. Human Chorionic Gonadotropin (hCG) 4.1.3. Thyroid Stimulating Hormone (TSH) 4.1.4. Dehydroepiandrosterone sulphate (DHEAS) 4.1.5. Prolactin 4.1.6. Progesterone 4.1.7. Insulin 4.1.8. Cortisol 4.1.9. Testosterone 4.1.10. Estradiol (E2) 4.1.11. Luteinizing Hormone (LH) 4.2. North America Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 4.2.1. Immunoassay 4.2.2. Clinical Chemistry 4.2.3. Monoclonal and Polyclonal Antibody 4.2.4. Sensor technology 4.2.5. Tandem Mass Spectroscopy 4.3. North America Endocrine Testing Market Size and Forecast, by End User (2022-2029) 4.3.1. Hospitals 4.3.2. Physician Offices 4.3.3. Health Care Centers 4.3.4. Commercial Laboratories 4.4. North America Endocrine Testing Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Endocrine Testing Market Size and Forecast, by Test (2022-2029) 4.4.1.1.1. Follicle stimulating hormone (FSH) 4.4.1.1.2. Human Chorionic Gonadotropin (hCG) 4.4.1.1.3. Thyroid Stimulating Hormone (TSH) 4.4.1.1.4. Dehydroepiandrosterone sulphate (DHEAS) 4.4.1.1.5. Prolactin 4.4.1.1.6. Progesterone 4.4.1.1.7. Insulin 4.4.1.1.8. Cortisol 4.4.1.1.9. Testosterone 4.4.1.1.10. Estradiol (E2) 4.4.1.1.11. Luteinizing Hormone (LH) 4.4.1.2. United States Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 4.4.1.2.1. Immunoassay 4.4.1.2.2. Clinical Chemistry 4.4.1.2.3. Monoclonal and Polyclonal Antibody 4.4.1.2.4. Sensor technology 4.4.1.2.5. Tandem Mass Spectroscopy 4.4.1.3. United States Endocrine Testing Market Size and Forecast, by End User (2022-2029) 4.4.1.3.1. Hospitals 4.4.1.3.2. Physician Offices 4.4.1.3.3. Health Care Centers 4.4.1.3.4. Commercial Laboratories 4.4.2. Canada 4.4.2.1. Canada Endocrine Testing Market Size and Forecast, by Test (2022-2029) 4.4.2.1.1. Follicle stimulating hormone (FSH) 4.4.2.1.2. Human Chorionic Gonadotropin (hCG) 4.4.2.1.3. Thyroid Stimulating Hormone (TSH) 4.4.2.1.4. Dehydroepiandrosterone sulphate (DHEAS) 4.4.2.1.5. Prolactin 4.4.2.1.6. Progesterone 4.4.2.1.7. Insulin 4.4.2.1.8. Cortisol 4.4.2.1.9. Testosterone 4.4.2.1.10. Estradiol (E2) 4.4.2.1.11. Luteinizing Hormone (LH) 4.4.2.2. Canada Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 4.4.2.2.1. Immunoassay 4.4.2.2.2. Clinical Chemistry 4.4.2.2.3. Monoclonal and Polyclonal Antibody 4.4.2.2.4. Sensor technology 4.4.2.2.5. Tandem Mass Spectroscopy 4.4.2.3. Canada Endocrine Testing Market Size and Forecast, by End User (2022-2029) 4.4.2.3.1. Hospitals 4.4.2.3.2. Physician Offices 4.4.2.3.3. Health Care Centers 4.4.2.3.4. Commercial Laboratories 4.4.3. Mexico 4.4.3.1. Mexico Endocrine Testing Market Size and Forecast, by Test (2022-2029) 4.4.3.1.1. Follicle stimulating hormone (FSH) 4.4.3.1.2. Human Chorionic Gonadotropin (hCG) 4.4.3.1.3. Thyroid Stimulating Hormone (TSH) 4.4.3.1.4. Dehydroepiandrosterone sulphate (DHEAS) 4.4.3.1.5. Prolactin 4.4.3.1.6. Progesterone 4.4.3.1.7. Insulin 4.4.3.1.8. Cortisol 4.4.3.1.9. Testosterone 4.4.3.1.10. Estradiol (E2) 4.4.3.1.11. Luteinizing Hormone (LH) 4.4.3.2. Mexico Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 4.4.3.2.1. Immunoassay 4.4.3.2.2. Clinical Chemistry 4.4.3.2.3. Monoclonal and Polyclonal Antibody 4.4.3.2.4. Sensor technology 4.4.3.2.5. Tandem Mass Spectroscopy 4.4.3.3. Mexico Endocrine Testing Market Size and Forecast, by End User (2022-2029) 4.4.3.3.1. Hospitals 4.4.3.3.2. Physician Offices 4.4.3.3.3. Health Care Centers 4.4.3.3.4. Commercial Laboratories 5. Europe Endocrine Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Endocrine Testing Market Size and Forecast, by Test (2022-2029) 5.2. Europe Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 5.3. Europe Endocrine Testing Market Size and Forecast, by End User (2022-2029) 5.4. Europe Endocrine Testing Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Endocrine Testing Market Size and Forecast, by Test (2022-2029) 5.4.1.2. United Kingdom Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 5.4.1.3. United Kingdom Endocrine Testing Market Size and Forecast, by End User (2022-2029) 5.4.2. France 5.4.2.1. France Endocrine Testing Market Size and Forecast, by Test (2022-2029) 5.4.2.2. France Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 5.4.2.3. France Endocrine Testing Market Size and Forecast, by End User (2022-2029) 5.4.3. Germany 5.4.3.1. Germany Endocrine Testing Market Size and Forecast, by Test (2022-2029) 5.4.3.2. Germany Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 5.4.3.3. Germany Endocrine Testing Market Size and Forecast, by End User (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Endocrine Testing Market Size and Forecast, by Test (2022-2029) 5.4.4.2. Italy Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 5.4.4.3. Italy Endocrine Testing Market Size and Forecast, by End User (2022-2029) 5.4.5. Spain 5.4.5.1. Spain Endocrine Testing Market Size and Forecast, by Test (2022-2029) 5.4.5.2. Spain Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 5.4.5.3. Spain Endocrine Testing Market Size and Forecast, by End User (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Endocrine Testing Market Size and Forecast, by Test (2022-2029) 5.4.6.2. Sweden Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 5.4.6.3. Sweden Endocrine Testing Market Size and Forecast, by End User (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Endocrine Testing Market Size and Forecast, by Test (2022-2029) 5.4.7.2. Austria Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 5.4.7.3. Austria Endocrine Testing Market Size and Forecast, by End User (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Endocrine Testing Market Size and Forecast, by Test (2022-2029) 5.4.8.2. Rest of Europe Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 5.4.8.3. Rest of Europe Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6. Asia Pacific Endocrine Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.2. Asia Pacific Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.3. Asia Pacific Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4. Asia Pacific Endocrine Testing Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.1.2. China Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.1.3. China Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.2.2. S Korea Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.2.3. S Korea Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.3.2. Japan Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.3.3. Japan Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4.4. India 6.4.4.1. India Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.4.2. India Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.4.3. India Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.5.2. Australia Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.5.3. Australia Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.6.2. Indonesia Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.6.3. Indonesia Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.7.2. Malaysia Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.7.3. Malaysia Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.8.2. Vietnam Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.8.3. Vietnam Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.9.2. Taiwan Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.9.3. Taiwan Endocrine Testing Market Size and Forecast, by End User (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Endocrine Testing Market Size and Forecast, by Test (2022-2029) 6.4.10.2. Rest of Asia Pacific Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 6.4.10.3. Rest of Asia Pacific Endocrine Testing Market Size and Forecast, by End User (2022-2029) 7. Middle East and Africa Endocrine Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Endocrine Testing Market Size and Forecast, by Test (2022-2029) 7.2. Middle East and Africa Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 7.3. Middle East and Africa Endocrine Testing Market Size and Forecast, by End User (2022-2029) 7.4. Middle East and Africa Endocrine Testing Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Endocrine Testing Market Size and Forecast, by Test (2022-2029) 7.4.1.2. South Africa Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 7.4.1.3. South Africa Endocrine Testing Market Size and Forecast, by End User (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Endocrine Testing Market Size and Forecast, by Test (2022-2029) 7.4.2.2. GCC Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 7.4.2.3. GCC Endocrine Testing Market Size and Forecast, by End User (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Endocrine Testing Market Size and Forecast, by Test (2022-2029) 7.4.3.2. Nigeria Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 7.4.3.3. Nigeria Endocrine Testing Market Size and Forecast, by End User (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Endocrine Testing Market Size and Forecast, by Test (2022-2029) 7.4.4.2. Rest of ME&A Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 7.4.4.3. Rest of ME&A Endocrine Testing Market Size and Forecast, by End User (2022-2029) 8. South America Endocrine Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Endocrine Testing Market Size and Forecast, by Test (2022-2029) 8.2. South America Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 8.3. South America Endocrine Testing Market Size and Forecast, by End User(2022-2029) 8.4. South America Endocrine Testing Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Endocrine Testing Market Size and Forecast, by Test (2022-2029) 8.4.1.2. Brazil Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 8.4.1.3. Brazil Endocrine Testing Market Size and Forecast, by End User (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Endocrine Testing Market Size and Forecast, by Test (2022-2029) 8.4.2.2. Argentina Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 8.4.2.3. Argentina Endocrine Testing Market Size and Forecast, by End User (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Endocrine Testing Market Size and Forecast, by Test (2022-2029) 8.4.3.2. Rest Of South America Endocrine Testing Market Size and Forecast, by Technology (2022-2029) 8.4.3.3. Rest Of South America Endocrine Testing Market Size and Forecast, by End User (2022-2029) 9. Global Endocrine Testing Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Endocrine Testing Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Thermo Fisher Scientific, Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Quest Technology 10.3. Biomedical Technologies. 10.4. Sysmex Corporation 10.5. Abbott Laboratories 10.6. AB Sciex Pte. Ltd. 10.7. Agilent Technologies 10.8. Siemens Healthcare 10.9. Ortho Clinical Technology 10.10. BioMerieux SA 10.11. Bio-Rad Laboratories 10.12. DiaSorin S.p.A 10.13. F. Hoffmann-La Roche Ltd. 10.14. Laboratory Corporation of America Holdings 10.15. Hoffmann-La Roche Ltd. 10.16. LabCorp 10.17. Alfa Aesar 10.18. Laboratory Corporation of America Holdings (LabCorp) 10.19. Beckman Coulter Inc 10.20. Teleflex Inc 11. Key Findings 12. Industry Recommendations 13. Endocrine Testing Market: Research Methodology 14. Terms and Glossary

Global Endocrine Testing Market